Stock CHEK CHECK-CAP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Check-Cap Ltd.

Equities

CHEK

IL0011336851

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 01:28:13 22/05/2024 am IST 		5-day change 1st Jan Change
2.215 USD +1.61% Intraday chart for Check-Cap Ltd. +1.14% +6.49%
26/03 Sector Update: Health Care Stocks Advance Late Afternoon MT
26/03 Check-Cap Shares Soar on Merger Deal With Fintech Firm Nobul MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 11.46 14.22 21.27 65.04 12.81 12.17
Enterprise Value (EV) 1 -2.79 6.955 3.865 14.62 -27.93 -12.59
P/E ratio -0.82 x -0.99 x -1.01 x -3.25 x -0.65 x -0.69 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA 0.26 x -0.5 x -0.28 x -0.85 x 1.42 x 0.71 x
EV / FCF 0.43 x -0.87 x -0.47 x -1.36 x 2.31 x 1.05 x
FCF Yield 232% -115% -214% -73.3% 43.3% 95%
Price to Book 0.88 x 2.28 x 1.3 x 1.28 x 0.31 x 0.51 x
Nbr of stocks (in thousands) 266 413 2,312 4,820 5,824 5,850
Reference price 2 43.00 34.40 9.200 13.49 2.200 2.080
Announcement Date 28/03/19 06/03/20 18/03/21 06/04/22 31/03/23 15/05/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -10.64 -13.95 -13.78 -17.12 -19.69 -17.65
EBIT 1 -10.78 -14.07 -13.93 -17.32 -20.03 -17.86
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -10.59 -13.84 -13.85 -17.2 -19.11 -17.57
Net income 1 -10.59 -13.84 -13.85 -17.2 -19.11 -17.57
Net margin - - - - - -
EPS 2 -52.19 -34.65 -9.124 -4.155 -3.369 -3.004
Free Cash Flow 1 -6.476 -7.974 -8.278 -10.71 -12.09 -11.95
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 28/03/19 06/03/20 18/03/21 06/04/22 31/03/23 15/05/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 - - - - - - - - -
EBITDA - - - - - - - - -
EBIT 1 -4.263 -5.578 -5.885 -4.888 -5.045 -4.215 -4.85 -6.063 -2.863
Operating Margin - - - - - - - - -
Earnings before Tax (EBT) 1 -4.241 -5.477 -5.834 -4.807 -4.754 -3.713 -4.442 -6.878 -2.59
Net income 1 -4.241 -5.477 -5.834 -4.807 -4.754 -3.713 -4.442 -6.878 -2.59
Net margin - - - - - - - - -
EPS 2 -0.8000 -1.200 -1.200 -0.8000 -0.8000 -0.6350 -0.7600 -1.180 -0.4400
Dividend per Share - - - - - - - - -
Announcement Date 03/11/21 06/04/22 01/06/22 31/08/22 30/11/22 31/03/23 11/05/23 04/08/23 27/11/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 14.2 7.26 17.4 50.4 40.7 24.8
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -6.48 -7.97 -8.28 -10.7 -12.1 -12
ROE (net income / shareholders' equity) -112% -144% -122% -51.3% -41.5% -54.1%
ROA (Net income/ Total Assets) -57.7% -70.7% -59.9% -28.8% -24.8% -31.7%
Assets 1 18.34 19.56 23.11 59.82 77.14 55.44
Book Value Per Share 2 48.90 15.10 7.080 10.50 7.070 4.050
Cash Flow per Share 2 32.20 18.60 3.330 5.490 0.7000 1.510
Capex 1 0.09 0.17 0.38 1.01 0.49 0.08
Capex / Sales - - - - - -
Announcement Date 28/03/19 06/03/20 18/03/21 06/04/22 31/03/23 15/05/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
CHECK-CAP LTD. Stock Check-Cap Ltd.
+6.49% 12.75M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-27.66% 9.41B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+26.94% 2.9B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-15.73% 2.16B
VERACYTE, INC. Stock Veracyte, Inc.
-20.83% 1.7B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+67.18% 1.51B
CAREDX, INC Stock CareDx, Inc
+26.08% 814M
SEEGENE, INC. Stock Seegene, Inc.
-4.15% 760M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-28.78% 529M
CURIOX BIOSYSTEMS CO., LTD Stock Curiox Biosystems Co., Ltd
+3.98% 312M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. CHEK Stock
  4. Financials Check-Cap Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW